Back
Intra-Cellular Therapies Stock Predictions
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
ITCI
Intra-Cellular Therapies
Last Price:
$131.70
Seasonality Move:
14.29%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Intra-Cellular Therapies Stock Forecast
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 34.2% based on the past 11 years of stock performance.
-
Intra-Cellular Therapies has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Intra-Cellular Therapies Stock Undervalued?The current Intra-Cellular Therapies [ITCI] share price is $131.70. The Score for ITCI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 34.2% based on the past 11 years of stock performance.
Intra-Cellular Therapies Stock Rating
Buy
57
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies overpriced?
-
Intra-Cellular Therapies has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
131.71
52-Week Low:
64.09
Prediction Charts
Market Cap:
14B
Price in USD:
131.70
Volume:
661K
Beta:
1.07
Technical Analysis
SMA50:
126.18
SMA100:
105.51
SMA200:
89.78
52-Wk Change:
90.81%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?Yes, Intra-Cellular Therapies is a publicly traded company.
-
What is the Intra-Cellular Therapies stock quote today?The Intra-Cellular Therapies stock price is 131.70 USD today.
-
How to buy Intra-Cellular Therapies stock online?You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-4 | 131.26 | 131.24 | 131.36 | 131.21 |
| Mar-5 | 131.28 | 131.19 | 131.35 | 131.18 |
| Mar-6 | 131.23 | 131.25 | 131.28 | 131.20 |
| Mar-7 | 131.30 | 131.24 | 131.32 | 131.21 |
| Mar-11 | 131.24 | 131.24 | 131.37 | 131.23 |
| Mar-12 | 131.25 | 131.25 | 131.33 | 131.19 |
| Mar-13 | 131.25 | 131.36 | 131.38 | 131.22 |
| Mar-14 | 131.28 | 131.26 | 131.40 | 131.24 |
| Mar-17 | 131.29 | 131.45 | 131.46 | 131.27 |
| Mar-18 | 131.42 | 131.45 | 131.48 | 131.35 |
| Mar-19 | 131.45 | 131.53 | 131.57 | 131.45 |
| Mar-20 | 131.55 | 131.60 | 131.60 | 131.50 |
| Mar-21 | 131.55 | 131.65 | 131.67 | 131.51 |
| Mar-24 | 131.58 | 131.70 | 131.71 | 131.58 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $3.58 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.